Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -5.17%45.850.0%$286.15m
HZNPHorizon Therapeutics Plc -3.75%99.845.4%$179.80m
VRXValeant Pharmaceuticals International, Inc. 1.11%23.7214.1%$139.57m
CTLTCatalent, Inc. -4.16%122.342.0%$139.08m
ICLRICON plc -0.09%272.812.8%$113.67m
JAZZJazz Pharmaceuticals Plc -1.99%120.262.1%$75.13m
UTHRUnited Therapeutics Corp. -1.74%185.9913.9%$72.82m
PRGOPerrigo Co. Plc -0.17%35.776.9%$61.33m
BHCBausch Health Cos., Inc. 1.11%23.720.0%$61.23m
ARGXargenx SE -3.80%283.700.0%$57.55m
CPIXCumberland Pharmaceuticals, Inc. 8.77%4.590.6%$53.98m
ENDPEndo International Plc -5.49%4.998.5%$43.65m
IRWDIronwood Pharmaceuticals, Inc. -1.17%10.989.5%$25.02m
PCRXPacira Biosciences, Inc. -2.27%52.539.8%$24.33m
AXSMAxsome Therapeutics, Inc. -3.33%32.241.8%$22.43m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.